Market Overview

Cowen & Co. Maintains Outperform on Alnylam Pharmaceuticals, Lowers Price Target to $147


This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of headlines on any catalyst that could move the stocks you care about on Benzinga Pro, our flagship platform for fast, actionable information that promotes faster, smarter trading.

Benzinga Pro has an intuitively designed workspace that delivers powerful market insight, and is the solution of choice for thousands of professional and retail traders across the world.

Stop Googling for information and check out Benzinga Pro. You will never again be left in the dark on when a stock moves. You’ll have what you need to act in real-time — before the crowd.

Start your FREE 14-day trial of Benzinga Pro today.

Latest Ratings for ALNY

Jan 2019UBSInitiates Coverage OnNeutral
Dec 2018GuggenheimInitiates Coverage OnBuy
Nov 2018Leerink SwannInitiates Coverage OnMarket Perform

View More Analyst Ratings for ALNY
View the Latest Analyst Ratings

Posted-In: News Price Target Analyst Ratings


Related Articles (ALNY)

Benzinga's Top Upgrades, Downgrades For August 13, 2018

26 Stocks Moving In Monday's Pre-Market Session